ArticleFrontiers in immunology2023

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.

Haijun Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.